Search Results

Your search matched 73 results

#1

Two-Thirds of Doctors Don't Trust Content on Pharma Sites | Blog

A recent survey by the Decision Resource Group reveals that only 34% of physicians feel that pharmaceutical websites are trustworthy.

#2

The Rise of Relevance Marketing | Blog

In many ways, our innovation practice is grounded in the concept of constant change.

#3

Meeker's Perennial Internet Trends Report Adds New Digital Health Section for 2017 | Blog

Mary Meeker's 2017 Internet Trends presentation captured new insights into dozens of digital advancements in healthcare

#4

Thoughts on Value-Based Arrangements from Industry Leaders | Blog

Lilly & Harvard Pilgrim Healthcare's CEOs shared their thoughts on value-based arrangements between pharma and payers

#5

A Sad Peek Behind the Curtain into US Physicians’ Views | Blog

Last month, the nation’s largest physician-owned malpractice insurer published results from a major survey focused on the attitudes, beliefs and behaviors of doctors today—and the results were sobering.

#6

The Fanciest Footwork in Brazil Can't Be Found in Rio… | Blog

With worldwide buzz being created by the 2016 Olympics in Rio, it would be easy to assume that Brazil’s biggest miracle in recent memory must involve an Olympian.

#7

eyeforpharma 2018: All the Highlights | Blog

A few weeks back, five colleagues and I attended the 16th annual eyeforpharma conference in Philadelphia.

#8

The Importance of Insights: 7 Key Take-Aways from GSK Insights Lead | Blog

Live from EFP ‘18: In his presentation “From ‘Data-as-Assets’ to ‘Insights-as-Assets,’” GSK’s VP of Commercial Insights Peter Barschdorff shared a hit list of wisdom in the space.

#9

Google is Your Doctor's Best Friend in a Pinch | Blog

The next time you see your busy doctor scratching her head in the office, there’s a good chance you might catch her consulting a colleague: Dr.

#10

Live from Trend Hunter Future Festival 2019 | Blog

Toronto-based innovation shop Trend Hunter has cranked out over 10,000 custom trends profiles in the past decade, and today they’ve compressed their annual 3-day innovation experience and taken their show on the road with an 8-hour intensive course.

#11

Big Pharma + Genetics Partnership | Blog

Recently, GSK and 23andMe announced a four-year collaboration aimed at identifying new drug targets, better supporting specific subpopulations and accelerating clinical progress.

#12

Fresh Stats—Pharma/Healthcare Digital Ad Spend | Blog

eMarketer’s latest numbers on Pharma’s digital ad spend are in, and the word of the day is growth.

#13

Well-Rested Docs Save Lives From the Other Side of the World | Blog

As you lie in the stiff hospital bed, you notice that it’s 3AM.

#14

Re-engineering Pills for the Future | Blog

The World Health Organization estimates that around half of all medications aren’t taken as directed.

#15

YouTube Presents: One Tremendous Opportunity to Reach Gen X | Blog

A recent survey commissioned by Google brings out powerful insights into the YouTube habits of a key demographic for many pharma brands: Generation X.

#16

Recent Study Finds Artificial Intelligence Doubles Medication Adherence | Blog

Study results published in the American Heart Association’s journal Stroke reveal that using AiCure’s AI-powered mobile app doubled anticoagulant adherence rates for stroke survivors.

#17

Voluntis + Sanofi's New Diabetes Therapy Goes Digital | Blog

Last week, pharmaceutical giant Sanofi and healthcare software pioneer Voluntis announced an expansion of their partnership focused on delivering digital therapy in the form of cutting-edge insulin titration tools.

#18

AI + Patients: The Future Is Now | Blog

On January 26th, MIT spinoff Empatica received FDA clearance for its epilepsy-tracking Embrace Watch — making it the first smartwatch approved in neurology in the US.

#19

MM&M’s Top 2018 Healthcare Trends in 2 Minutes or Less | Blog

MM&M recently shared a series of infographics to visualize their top healthcare trends for 2018.

#20

Amazonian Innovation: It’s as Easy as 3-2-1 | Blog

Before this year’s 16th annual eyeforpharma convention even officially began, Amazon was there, empowering pharma leaders by teaching them new ways from their approach to innovation.

#21

Font for Forgetful Folks | Blog

In recent weeks, a group of researchers, behavioral scientists and typographic design specialists from down under have given the world an unforgettable new tool: a new font called Sans Forgetica.

#22

AI + Genetics + Patients = Win | Blog

A few weeks back, the digital healthcare company Optra Health announced the launch of OptraGURU, its newest platform that leverages the AI tech of its iPhronesis offering with Amazon Alexa’s natural language skills.

#23

AI Saves Lives | Blog

Flying in the face of Sarah Connor and Elon Musk’s worst fears, artificial intelligence is saving lives worldwide.

#24

Introducing Amazon’s New and Exclusive Medical Device Brand | Blog

In recent weeks, Amazon and Arcadia Group announced the launch of a series of consumer-grade medical devices under their new brand Choice.

#25

Algorithms Unleashed | Blog

Live from EFP ‘18: Bharat Tewarie, EVP & Chief Marketing Officer at UCB shared his perspective on AI’s evolving role in pharma.

#26

eyeforpharma Philadelphia 2018—Staring with Trust? | Blog

Live from EFP ‘18: Today, eyeforpharma Philadelphia opened with one word: trust.

#27

Stressed About Your Diet? | Blog

For those of us squarely in the mid-latitudes of the northern hemisphere, fall is upon us, and that means more than PSLs to our Innovation team—trendspotting season is well underway.

#28

Betting Big on Cancer.com | Blog

This month, Janssen launched Cancer.com, aiming to create an online destination for all things oncology.

#29

Diabetes Rates on the Decline: the Good News and the Bad | Blog

While general diabetes incidence is declining in the US, several populations aren’t seeing the same progress.

#30

eyeforpharma Philadelphia 2019 Opening Session Takeaways | Blog

Live from eyeforpharma Philadelphia 2019— eyeforpharma Chairperson Paul Simms kicked off today’s conference with 5 bold predictions for our industry.